IDEAYA Biosciences Hosts Investor R&D Day to Highlight Oncology Pipeline

Bitget2026/11/04 11:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

IDEAYA Biosciences will host its Investor R&D Day in London on November 16, 2026, at 5 p.m. GMT.
The event will cover IDE892 Phase 1 data and RAS-focused combination strategies.
CEO Yujiro S. Hata will join the UBS Global Biopharma Conference fireside chat November 16, 2026, at 10:40 a.m. GMT in London.
Management will participate in the Jefferies Global Healthcare Conference November 17, 2026, at 1 p.m. GMT in London.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEAYA Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611040600PR_NEWS_USPR_____SF88540) on November 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

IDEAYA Biosciences Hosts Investor R&D Day to Highlight Oncology Pipeline

You may also like

Crypto prices